Investors
Forbion Capital Partners
https://forbion.comForbion Capital Partners is a venture capital fund based in Amsterdam. They invest in early to later-stage companies in the biotech, health tech, and pharmaceutical sectors, with investments ranging from $250k to $5 million. Notable investments include SynOx Therapeutics and Calluna Pharma. Forbion Capital Partners focuses on supporting businesses developing new medical treatments and technologies.
Recent Investments
- Pheon TherapeuticsSeries B(
70 ) - Seamless TherapeuticsSeed( 33 )
- Calluna PharmaSeries A( 52 )
- Orbis MedicinesSeed( 44 )
- SynOx TherapeuticsSeries B( 56 )
- Tessellate BIOSeed( 41 )
- DualyxSeries A( 41 )
- Complement TherapeuticsSeries A( 60 )
- VectorYSeries A( 56 )
- Noema PharmaSeries B( 48 )
- AAVantgarde BioSeries A( 52 )
- CatalYmUnknown( 56 )
- Pheon TherapeuticsSeries A( 70 )
- F2GUnknown( 48 )
- PrecirixSeries B( 52 )
- VectorYSeed( 56 )
- NorthSea TherapeuticsSeries C( 56 )
- Mestag TherapeuticsUnknown( 44 )
- AnaveonUnknown( 48 )
- Achilles TherapeuticsSeries C( 60 )
- NorthSea TherapeuticsSeries B( 56 )
- CatalYmSeries B( 56 )
- SynOx TherapeuticsUnknown( 56 )
- Achilles TherapeuticsSeries B( 60 )
- Enterprise TherapeuticsSeries B( 52 )
- NorthSea TherapeuticsSeries A( 56 )